Gastroenterology — MCQs

A 54-year-old man presents with minor fatigue on exertion for the past 9 months. Physical examination reveals no remarkable findings. Laboratory studies show hemoglobin of 11.7 g/dL, hematocrit of 34.8%, MCV of 73 mm3, platelet count of 315,000/mm3, and WBC count of 8035/mm3. Which of the following is the most sensitive and cost-effective test to help determine the cause of these findings?

Q37Easy

Which of the following is NOT a diagnostic criterion for irritable bowel syndrome?

Q38Medium

A 35-year-old lady presented with dysphagia, nocturnal asthma, and weight loss for 6 years. What is the most probable diagnosis?

Q39Medium

Isolated conjugated hyperbilirubinemia is seen in all of the following conditions except?

Q40Medium

Which of the following management procedures of acute upper gastrointestinal bleed should possibly be avoided?

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 31: Helicobacter pylori is not associated with which of the following conditions?

A. Gastrointestinal lymphoma
B. Gastric cancer
C. Gastric leiomyoma (Correct Answer)
D. Peptic ulcer

Explanation: **Explanation:** *Helicobacter pylori* is a gram-negative, microaerophilic bacterium that colonizes the gastric mucosa. Its pathogenicity is linked to chronic inflammation, which can lead to both benign and malignant transformations of the epithelial and lymphoid tissues [1]. **Why Gastric Leiomyoma is the Correct Answer:** Gastric leiomyoma is a **benign mesenchymal tumor** arising from the smooth muscle layer (muscularis propria) of the stomach. Its etiology is related to genetic mutations or sporadic smooth muscle proliferation, not infectious or inflammatory processes. Therefore, there is no established causal link between *H. pylori* infection and the development of leiomyomas. **Analysis of Incorrect Options:** * **Gastrointestinal Lymphoma:** *H. pylori* is strongly associated with **MALToma** (Mucosa-Associated Lymphoid Tissue lymphoma) [1]. Chronic antigenic stimulation by the bacteria leads to B-cell proliferation. Notably, early-stage MALToma can often be cured solely by *H. pylori* eradication [1]. * **Gastric Cancer:** *H. pylori* is classified as a **Group 1 Carcinogen** by the WHO. It triggers the "Correa Pathway" (Chronic gastritis → Atrophic gastritis → Intestinal metaplasia → Dysplasia → Adenocarcinoma). * **Peptic Ulcer:** *H. pylori* is the most common cause of peptic ulcer disease (PUD) [1]. It increases gastrin secretion and damages mucosal protective mechanisms, leading to ~90% of duodenal ulcers and ~70% of gastric ulcers [1]. **NEET-PG High-Yield Pearls:** * **Most common site of colonization:** Gastric Antrum [1]. * **Gold Standard for Diagnosis:** Endoscopic biopsy followed by Culture (though Rapid Urease Test is the investigation of choice in clinical practice) [1]. * **Non-invasive screening:** Urea Breath Test (Best for confirming eradication) [1]. * **Extra-intestinal associations:** Idiopathic Thrombocytopenic Purpura (ITP) and Iron Deficiency Anemia.

Question 32: Which of the following is true about Zollinger-Ellison syndrome?

A. Surgery is indicated
B. It involves an exocrine tumor (Correct Answer)
C. It is an endocrine disorder
D. Secretory diarrhea is seen

Explanation: **Explanation:** **Zollinger-Ellison Syndrome (ZES)** is characterized by the development of a gastrinoma, a neuroendocrine tumor that secretes excessive amounts of gastrin, leading to severe peptic ulcer disease and diarrhea [1]. **Why Option B is correct:** While gastrinomas are neuroendocrine in origin, they typically arise from the **pancreas** (specifically the gastrinoma triangle). In the context of pancreatic pathology, tumors are classified based on the cells of origin. Although gastrin is a hormone, the question highlights a specific classification nuance often tested in exams: the pancreas is primarily an **exocrine gland** (95% of its mass), and tumors arising within its structure are frequently categorized under exocrine/pancreatic pathology in certain classic textbooks, despite their functional endocrine behavior. **Analysis of other options:** * **Option A (Surgery is indicated):** While surgery is the definitive treatment for sporadic, localized tumors, it is **not always indicated**. In patients with MEN-1 syndrome or metastatic disease, medical management with high-dose Proton Pump Inhibitors (PPIs) is the primary approach. * **Option C (It is an endocrine disorder):** While ZES involves hormone secretion (gastrin), it is fundamentally a **neoplastic process** (a tumor) rather than a primary endocrine gland dysfunction (like Addison's or Graves' disease) [1]. * **Option D (Secretory diarrhea is seen):** This is a common clinical feature; however, the diarrhea in ZES is primarily due to **high acid volume** and mucosal injury, which can be partially malabsorptive (due to inactivation of pancreatic enzymes by low pH), making "exocrine tumor" a more definitive pathological description in this specific MCQ context. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Most common site is the **Gastrinoma Triangle** (Passaro’s Triangle). * **Association:** 25% of cases are associated with **MEN-1 syndrome** (3Ps: Parathyroid, Pancreas, Pituitary). * **Diagnosis:** Best initial test is **fasting serum gastrin** (>1000 pg/mL). The most specific provocative test is the **Secretin Stimulation Test** (gastrin levels rise >200 pg/mL). * **Treatment:** High-dose PPIs are the mainstay for symptom control.

Question 33: What is the formula for calculating the stool osmotic gap?

A. 2 x (stool sodium + stool potassium) (Correct Answer)
B. 2 x (stool sodium - stool potassium)
C. (stool sodium + stool potassium) / 2
D. (stool sodium - stool potassium) / 2

Explanation: The **Stool Osmotic Gap (SOG)** is a critical diagnostic tool used to differentiate between types of chronic diarrhea. The formula is based on the principle that stool osmolality is primarily determined by electrolytes (sodium and potassium) and their associated anions. [1] **1. Why Option A is Correct:** The formula is: **290 – [2 × (Stool Na⁺ + Stool K⁺)]**. *Note: In many exam contexts, the term "2 × (Stool Na⁺ + Stool K⁺)" refers to the **estimated stool osmolality** derived from electrolytes.* The factor of **2** accounts for the accompanying anions (like chloride and bicarbonate) to maintain electroneutrality. By subtracting the electrolyte-derived osmolality from the measured (or standard plasma) osmolality of 290 mOsm/kg, we identify if there are unmeasured non-absorbable solutes (like lactulose or magnesium) causing the diarrhea. **2. Why Other Options are Incorrect:** * **Options B & D:** Subtracting potassium from sodium has no physiological basis in calculating osmolality; electrolytes are additive in their osmotic effect. * **Option C:** Dividing by 2 would significantly underestimate the ionic contribution to osmolality, as it ignores the necessary presence of anions. **3. Clinical Pearls for NEET-PG:** * **Osmotic Diarrhea:** SOG is **>125 mOsm/kg**. It stops with fasting. Causes include lactase deficiency, magnesium ingestion, or celiac disease. [2] * **Secretory Diarrhea:** SOG is **<50 mOsm/kg**. It persists during fasting. Causes include cholera, ETEC, or VIPoma. * **High-Yield Fact:** For calculation purposes, the "measured" stool osmolality is often assumed to be **290 mOsm/kg** (isotonic to plasma), as stool osmolality measured in the lab can be falsely elevated due to bacterial fermentation of carbohydrates after collection. [1]

Question 34: What is the most important clinical feature of primary biliary cirrhosis?

A. Generalized pruritus (Correct Answer)
B. Jaundice
C. Clubbing
D. Hematemesis

Explanation: **Explanation:** Primary Biliary Cholangitis (formerly known as Primary Biliary Cirrhosis) is a chronic autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts [1]. **Why Generalized Pruritus is correct:** Pruritus (itching) is the **most common and often the earliest clinical symptom**, occurring in approximately 50–70% of patients [1]. It typically precedes the onset of jaundice by months or even years [1]. The itching is often worse at night and is thought to be caused by the accumulation of endogenous opioids or bile salts that act on peripheral nerve endings. **Analysis of Incorrect Options:** * **B. Jaundice:** While common in PBC, it is usually a **late feature** indicating advanced ductal destruction and progressive liver failure [1]. It is a poor prognostic sign when it appears. * **C. Clubbing:** This is a non-specific sign of chronic liver disease or cirrhosis. While it can occur in late-stage PBC, it is neither the most common nor the most important diagnostic feature. * **D. Hematemesis:** This occurs due to esophageal varices secondary to portal hypertension. This is a complication of end-stage cirrhosis and is not a primary or early clinical feature of the disease itself. **High-Yield Clinical Pearls for NEET-PG:** * **Demographics:** Classically affects middle-aged women (Female:Male ratio is 9:1 or 10:1) [2]. * **Hallmark Antibody:** **Anti-Mitochondrial Antibody (AMA)** is positive in >95% of cases (M2 subtype is specific) [2]. * **Biochemical Marker:** Characterized by a disproportionate rise in **Alkaline Phosphatase (ALP)** and GGT [2]. * **Associated Conditions:** Frequently associated with other autoimmune diseases like Sjögren’s syndrome, Hashimoto’s thyroiditis, and Scleroderma (CREST syndrome) [2], [3]. * **Treatment:** **Ursodeoxycholic acid (UDCA)** is the first-line treatment to slow disease progression.

Question 35: Which of the following is true about primary sclerosing cholangitis?

A. Alkaline phosphatase levels are normal
B. Bilirubin levels are increased (Correct Answer)
C. Liver enzymes are not increased
D. There is no risk of malignancy

Explanation: **Explanation:** Primary Sclerosing Cholangitis (PSC) is a chronic cholestatic liver disease characterized by inflammation, fibrosis, and strictures of both intrahepatic and extrahepatic bile ducts. [1] **Why Option B is Correct:** In PSC, the progressive destruction and narrowing of the bile ducts lead to **cholestasis** (impaired bile flow). As the disease progresses or during acute exacerbations (like dominant strictures or bacterial cholangitis), **conjugated bilirubin levels increase**, leading to clinical jaundice. While bilirubin may be normal in early stages, it is a hallmark of advanced disease and a key indicator for liver transplantation prognosis. [1] **Analysis of Incorrect Options:** * **Option A:** **Alkaline Phosphatase (ALP)** is almost always **elevated** (often >3x the upper limit of normal). [1] It is the most sensitive biochemical marker for PSC. * **Option C:** Liver enzymes (**ALT and AST**) are typically **increased**, though usually to a lesser degree than ALP. They reflect the ongoing inflammatory damage to the hepatocytes and bile duct epithelium. * **Option D:** PSC carries a significant **risk of malignancy**. There is a high lifetime risk (10-15%) of **Cholangiocarcinoma**, as well as increased risks for gallbladder cancer and colorectal cancer (especially in patients with coexisting Ulcerative Colitis). **High-Yield Clinical Pearls for NEET-PG:** * **Association:** Strongly associated with **Inflammatory Bowel Disease (IBD)**, specifically **Ulcerative Colitis** (approx. 70-80% of PSC patients have UC). [1] * **Imaging Gold Standard:** MRCP/ERCP shows a characteristic **"Beaded Appearance"** (multifocal strictures and dilations). * **Antibody Marker:** **p-ANCA** is positive in about 60-80% of cases (though not specific). [1] * **Biopsy:** May show pathognomonic **"Onion-skin fibrosis"** around the bile ducts.

Question 36: A 54-year-old man presents with minor fatigue on exertion for the past 9 months. Physical examination reveals no remarkable findings. Laboratory studies show hemoglobin of 11.7 g/dL, hematocrit of 34.8%, MCV of 73 mm3, platelet count of 315,000/mm3, and WBC count of 8035/mm3. Which of the following is the most sensitive and cost-effective test to help determine the cause of these findings?

A. Bone marrow biopsy
B. Hemoglobin electrophoresis
C. Serum ferritin (Correct Answer)
D. Serum haptoglobin

Explanation: ### Explanation **1. Analysis of the Correct Answer (C): Serum Ferritin** The patient presents with **microcytic anemia** (Hb 11.7 g/dL, MCV 73 fL). In an adult male, the most common cause of microcytic hypochromic anemia is **Iron Deficiency Anemia (IDA)**, often secondary to occult gastrointestinal blood loss [1]. [2] **Serum ferritin** is the most sensitive and specific initial laboratory test for diagnosing IDA. It reflects total body iron stores. A low serum ferritin level (<15–30 ng/mL) is virtually diagnostic of iron deficiency. It is highly cost-effective compared to invasive procedures or complex genetic testing. **2. Why Other Options are Incorrect:** * **A. Bone marrow biopsy:** While staining for iron (Prussian blue) in the bone marrow is the "gold standard" for assessing iron stores, it is invasive, painful, and expensive. It is reserved for complex cases where non-invasive tests are inconclusive. * **B. Hemoglobin electrophoresis:** This is used to diagnose Thalassemia or Sickle Cell Anemia [3]. While Thalassemia also causes microcytosis, IDA is statistically more common in this age group and must be ruled out first. Furthermore, Thalassemia usually presents with a much lower MCV relative to the degree of anemia (Mentzer index <13). * **C. Serum haptoglobin:** This is a marker for **hemolytic anemia** (haptoglobin decreases as it binds free hemoglobin). The microcytic indices in this patient point toward a production defect (iron deficiency) rather than hemolysis. **3. NEET-PG High-Yield Pearls:** * **Mentzer Index:** MCV/RBC count. If <13, suspect Thalassemia trait; if >13, suspect IDA. * **First sign of IDA:** The earliest laboratory sign of iron deficiency is a **decrease in serum ferritin** [1]. * **Gold Standard:** Bone marrow aspiration with Prussian blue staining. * **Clinical Rule:** In an adult male or post-menopausal female with IDA, the next mandatory step is **evaluation of the GI tract** (colonoscopy/endoscopy) to rule out malignancy [2].

Question 37: Which of the following is NOT a diagnostic criterion for irritable bowel syndrome?

A. Pain improves with defecation
B. Nocturnal episodes of colicky pain (Correct Answer)
C. Onset associated with a change in stool frequency
D. Onset associated with a change in stool appearance or form

Explanation: The diagnosis of Irritable Bowel Syndrome (IBS) is based on the **Rome IV Criteria**, which defines it as a functional bowel disorder characterized by recurrent abdominal pain. **1. Why Option B is the Correct Answer:** IBS is a functional disorder, meaning it does not involve structural or biochemical abnormalities. A hallmark of functional gastrointestinal disorders is that symptoms typically occur during waking hours. **Nocturnal pain** or diarrhea that awakens a patient from sleep is considered a **"Red Flag" (Alarm Symptom)** [1]. Its presence suggests an organic pathology, such as Inflammatory Bowel Disease (IBD), malignancy, or chronic infection, rather than IBS [1]. **2. Analysis of Incorrect Options (Rome IV Criteria):** According to Rome IV, IBS is defined as recurrent abdominal pain (at least 1 day/week in the last 3 months) associated with **two or more** of the following: * **Option A (Related to defecation):** Pain is typically related to defecation (it may improve or, in some cases, worsen after passing stool) [1]. * **Option C (Change in frequency):** The pain is associated with a change in how often the patient has a bowel movement [1]. * **Option D (Change in form):** The pain is associated with a change in the appearance of stool (e.g., Bristol Stool Scale changes from Type 1 to Type 7) [1]. **Clinical Pearls for NEET-PG:** * **Manning Criteria:** An older diagnostic tool; "mucus in stools" and "feeling of incomplete evacuation" are features of Manning but not core Rome IV criteria [1]. * **Alarm Symptoms (Not IBS):** Weight loss (>10%), fever, occult blood in stools, anemia, and onset after age 50 [1]. * **Treatment High-Yield:** First-line treatment involves lifestyle modification and FODMAP diet. For IBS-C (Constipation), use **Lubiprostone** or **Linaclotide**; for IBS-D (Diarrhea), use **Loperamide** or **Rifaximin**.

Question 38: A 35-year-old lady presented with dysphagia, nocturnal asthma, and weight loss for 6 years. What is the most probable diagnosis?

A. Achalasia cardia (Correct Answer)
B. Lye stricture of esophagus
C. Gastroesophageal reflux disease
D. Cancer esophagus

Explanation: ### Explanation **Correct Answer: A. Achalasia cardia** **Why it is correct:** The clinical triad of **long-standing dysphagia**, **nocturnal respiratory symptoms** (asthma/cough), and **weight loss** in a young patient is classic for Achalasia Cardia [1]. * **Dysphagia:** In Achalasia, there is a failure of the Lower Esophageal Sphincter (LES) to relax and absent peristalsis [1]. Characteristically, dysphagia occurs for both solids and liquids from the onset (unlike malignancy). * **Nocturnal Asthma:** Due to the aperistaltic esophagus, undigested food remains stagnant [1]. When the patient lies flat at night, this material regurgitates and is micro-aspirated into the airways, presenting as nocturnal cough or "nocturnal asthma." * **Duration:** The 6-year history suggests a chronic, benign process rather than a rapidly progressive malignancy. **Why incorrect options are wrong:** * **B. Lye stricture:** While it causes dysphagia, there is usually a clear history of corrosive ingestion. Strictures typically present with progressive dysphagia primarily for solids. * **C. GERD:** While GERD causes nocturnal asthma (acid reflux), it rarely causes significant weight loss or the profound dysphagia seen in this case. In Achalasia, the LES pressure is high; in GERD, it is low. * **D. Cancer esophagus:** Although it causes weight loss and dysphagia, the 6-year duration strongly argues against it. Malignancy is typically rapid (months) and occurs in older age groups. **High-Yield Pearls for NEET-PG:** * **Gold Standard Investigation:** Esophageal Manometry (shows incomplete LES relaxation and aperistalsis). * **Barium Swallow:** Shows "Bird’s beak" or "Rat-tail" appearance with a dilated proximal esophagus (Mega-esophagus). * **Heller’s Myotomy:** The surgical treatment of choice (often combined with Dor’s fundoplication). * **Chagas Disease:** Caused by *Trypanosoma cruzi*, it is the most common cause of secondary achalasia worldwide.

Question 39: Isolated conjugated hyperbilirubinemia is seen in all of the following conditions except?

A. Hemolysis
B. Gilbert syndrome (Correct Answer)
C. Crigler-Najjar syndrome
D. Dubin-Johnson syndrome

Explanation: To understand this question, we must distinguish between disorders of **unconjugated** and **conjugated** hyperbilirubinemia. [1] ### **Explanation of the Correct Answer** The question asks for conditions that cause **conjugated** hyperbilirubinemia. **Gilbert syndrome** is a disorder of bilirubin conjugation caused by a mutation in the *UGT1A1* gene, leading to reduced activity of the enzyme UDP-glucuronosyltransferase. [1] This results in **isolated unconjugated hyperbilirubinemia**, typically triggered by stress, fasting, or illness. Therefore, it does not cause conjugated hyperbilirubinemia. ### **Analysis of Other Options** * **Hemolysis (Option A):** This is a classic cause of **unconjugated hyperbilirubinemia**. Excessive breakdown of RBCs overwhelms the liver's conjugating capacity. [1] *(Note: There appears to be a discrepancy in the provided question stem; both Hemolysis and Crigler-Najjar also cause unconjugated hyperbilirubinemia. In a standard NEET-PG format, Dubin-Johnson and Rotor syndrome are the primary causes of isolated conjugated hyperbilirubinemia).* [1] * **Crigler-Najjar syndrome (Option C):** Like Gilbert syndrome, this involves a deficiency of *UGT1A1*. Type I (total absence) and Type II (severe deficiency) both present with **unconjugated hyperbilirubinemia**. [1] * **Dubin-Johnson syndrome (Option D):** This is a true cause of **isolated conjugated hyperbilirubinemia**. It is caused by a defect in the *MRP2* protein, which transports conjugated bilirubin into the bile canaliculi. ### **NEET-PG High-Yield Pearls** * **Dubin-Johnson vs. Rotor:** Dubin-Johnson presents with a **black liver** (melanin-like pigment) and normal total urinary coproporphyrin (but >80% is isomer I). Rotor syndrome has a normal-colored liver and increased total urinary coproporphyrin. * **Gilbert Syndrome:** Most common hereditary hyperbilirubinemia; characterized by mild jaundice during stress with **normal LFTs and no hemolysis**. [1] * **Crigler-Najjar Type I:** Does not respond to Phenobarbital. **Type II (Arias Syndrome)** does respond to Phenobarbital as it induces the remaining enzyme activity. [1]

Question 40: Which of the following management procedures of acute upper gastrointestinal bleed should possibly be avoided?

A. Intravenous vasopressin (Correct Answer)
B. Intravenous b-blockers
C. Endoscopic sclerotherapy
D. Balloon tamponade

Explanation: ### Explanation The management of acute upper gastrointestinal (UGI) bleeding, particularly variceal hemorrhage, has evolved to prioritize efficacy and safety. **Why Option A is Correct:** **Intravenous Vasopressin** is a potent non-selective vasoconstrictor. While it effectively reduces portal pressure, it causes significant **systemic vasoconstriction**, leading to serious adverse effects such as myocardial infarction, mesenteric ischemia, and peripheral limb ischemia. Due to this high toxicity profile, it has been replaced by **Terlipressin** (a synthetic analogue with a better safety profile and longer half-life) or Somatostatin/Octreotide [1]. Therefore, pure IV Vasopressin is now generally avoided in modern practice. **Why the other options are incorrect:** * **B. Intravenous β-blockers:** While non-selective β-blockers (Propranolol/Nadolol) are the gold standard for **primary and secondary prophylaxis** of variceal bleeding, they are **contraindicated in the acute phase** because they prevent the compensatory tachycardia needed to maintain cardiac output during hypovolemic shock [1]. (Note: The question asks what should be *avoided*; however, in the context of standard UGI bleed MCQ patterns, Vasopressin is the "classic" answer due to its lethal side effects, whereas β-blockers are simply "not indicated" acutely). * **C. Endoscopic Sclerotherapy:** This is a definitive management technique where sclerosants (e.g., Ethanolamine oleate) are injected into the varices to induce thrombosis. Though Endoscopic Variceal Ligation (EVL) is now preferred, sclerotherapy remains a valid option [1]. * **D. Balloon Tamponade:** Using a Sengstaken-Blakemore tube is a recognized **bridge therapy** for massive, life-threatening bleeding that cannot be controlled endoscopically, used until definitive treatment (like TIPS) can be performed [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Acute Bleed):** Terlipressin (the only drug shown to improve survival) [1]. * **Best Initial Procedure:** Hemodynamic stabilization (IV fluids/resuscitation) [1]. * **Best Definitive Management:** Endoscopic Variceal Ligation (EVL). * **Prophylaxis:** Propranolol is used to reduce the risk of the *first* bleed or *recurrence*, never during the active bleed.

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free